SEC Form 4 · accession 0001144204-18-033791
AVENUE THERAPEUTICS, INC. · ATXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lindsay A Rosenwald M.D.
Director
Period of report
Jun 8, 2018
Accepted (ET)
Jun 11, 2018 · 5:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001644963
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 8, 2018 | P | 5,234 | $4.34 | A | 25,234 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Weighted average price. These shares were purchased in multiple transactions ranging from $4.20 to $4.40. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth.
- F2Includes 10,000 shares of restricted stock.